Latest news & insights
Eamonn McGowran explains developments in regulation for medical devices in Med-Tech Innovation article
An article published in Med-Tech Innovation and authored by Eamonn McGowran, explains the developments in regulation for Medical devices.
Dr Karen Mullen interviewed for pharmaphorum article
Dr Karen Mullen, Chief Medical Officer at Boyds, recently sat down with pharmaphorum, a leading online destination for healthcare and pharmaceutical industry news.
Boyds regulatory affairs article published by Drug Discovery World
An article authored by Dr Julie Warner, Vice President of Regulatory Affairs, has been featured by Drug Discovery World – the multi-platform global voice for the drug discovery community.
Boyds article published by Clinical Leader
An article authored by Dr Harriet Gray Stephens, Pharmaceutical Physician in Boyds’ Clinical and Medical Affairs team has been featured by Clinical Leader – a
Boyds bolsters regulatory affairs team with key appointment
We are delighted to announce the appointment of experienced regulatory affairs professional and cell and gene therapy expert Dr Patrick Ginty. With 17 years’ R&D
Boyds expands regulatory affairs team with experienced senior hire of Katherine Bowen
We are delighted to announce the appointment of experienced regulatory affairs professional Katherine Bowen in response to a rise in demand for our specialist regulatory
Boyds US Office: celebrating one year
Boyds took the bold step to open its US office in September 2021, appointing Katy Rudnick as Vice President and Head of US Regulatory Affairs
Further growth for Boyds’ clinical operations team with hire of Chris Moore
We are delighted to announce the appointment of Chris Moore as Clinical Project Manager to support growing demand for our specialist clinical trial expertise. As
